We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$16.5B
AUM Growth
-$1.93B
(-10%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-13.67%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
1,547
New
416
Increased
366
Reduced
319
Closed
426
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$233M |
| 2 |
TSMC
TSM
|
+$222M |
| 3 |
Philip Morris
PM
|
+$189M |
| 4 |
Qualcomm
QCOM
|
+$171M |
| 5 |
AstraZeneca
AZN
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$396M |
| 2 |
Citigroup
C
|
+$269M |
| 3 |
Cisco
CSCO
|
+$253M |
| 4 |
Boeing
BA
|
+$166M |
| 5 |
Bank of America
BAC
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.96% |
| 2 | Technology | 21.61% |
| 3 | Consumer Staples | 8.79% |
| 4 | Communication Services | 8.54% |
| 5 | Financials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Infosys
INFY
$51B
| $138M | 0.83% |
20,305,408
+3,868,752
| +24% | +$28.1M |
|
27
Archer Daniels Midland
ADM
$38.5B
| $136M | 0.82% |
3,128,050
-1,218,009
| -28% | -$50.2M |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $135M | 0.81% |
1,930,062
+4,784
| +0.2% | +$379K |
|
29
Pfizer
PFE
$145B
| $130M | 0.79% |
4,274,532
-5,420,735
| -56% | -$162M |
|
|
30
Cisco
CSCO
$480B
| $128M | 0.78% |
5,719,409
-11,450,133
| -67% | -$253M |
|
31
American International
AIG
$42.1B
| $122M | 0.74% |
2,447,926
-3,251,788
| -57% | -$162M |
|
32
Boston Scientific
BSX
$71.1B
| $114M | 0.69% |
8,437,629
-1,047,601
| -11% | -$13.8M |
|
33
Intel
INTC
$509B
| $112M | 0.68% |
4,325,398
+1,556,906
| +56% | +$38.9M |
|
34
Marvell Technology
MRVL
$196B
| $110M | 0.67% |
7,011,046
-401,327
| -5% | -$6.14M |
|
35
Amgen
AMGN
$210B
| $105M | 0.64% |
851,192
-800,168
| -48% | -$97M |
|
|
CERN
36
DELISTED
Cerner Corp
CERN
| $102M | 0.62% |
1,818,683
+398,251
| +28% | +$23M |
|
37
AutoZone
AZO
$49.4B
| $102M | 0.61% |
189,046
-118,884
| -39% | -$61.7M |
|
38
Western Digital
WDC
$189B
| $99.1M | 0.6% |
1,427,411
-321,226
| -18% | -$21M |
|
|
CMCSK
39
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $96.8M | 0.59% |
1,985,704
+156,203
| +9% | +$7.62M |
|
40
Thomson Reuters
TRI
$47.6B
| $93.5M | 0.57% |
2,352,104
+478,703
| +26% | +$19.6M |
|
|
TWC
41
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $92.5M | 0.56% |
674,095
+655,524
| +3,530% | +$89.7M |
|
42
Xerox
XRX
$424M
| $89.6M | 0.54% |
3,009,508
+1,100,005
| +58% | +$32.2M |
|
43
Nokia
NOK
$55.4B
| $88.2M | 0.53% |
12,012,310
+4,616,529
| +62% | +$34.6M |
|
44
Bausch Health
BHC
$2.41B
| $87.2M | 0.53% |
661,758
+476,565
| +257% | +$65.2M |
|
|
AGN
45
DELISTED
Allergan plc
AGN
| $87.1M | 0.53% |
423,223
+286,395
| +209% | +$56.7M |
|
46
NetApp
NTAP
$37.4B
| $85.5M | 0.52% |
2,316,615
+723,021
| +45% | +$29.2M |
|
47
CVS Health
CVS
$133B
| $83.7M | 0.51% |
+1,118,368
| New | +$79M |
|
48
Canadian Natural Resources
CNQ
$96.3B
| $83.7M | 0.51% |
4,509,842
+2,567,732
| +132% | +$43.4M |
|
49
NVIDIA
NVDA
$5.13T
| $79.8M | 0.48% |
178,259,280
-91,560
| -0.1% | -$39.2K |
|
50
Regions Financial
RF
$27.3B
| $79.6M | 0.48% |
7,164,809
-1,099,824
| -13% | -$11.6M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Arrowstreet Capital held 1,547 positions worth $16.5B, down 10% from $18.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital withdrew a net $2.26B in Q1 2014, closing 426 positions and reducing 319 holdings. Its most notable exit was GE Aerospace, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in Philip Morris worth $192M.
- Arrowstreet Capital's largest Q1 2014 buy was Philip Morris: 2,344,576 shares worth $192M.
- Arrowstreet Capital added most to GSK in Q1 2014, an estimated $233M increase.
- Arrowstreet Capital's biggest Q1 2014 reduction was Vodafone, cutting an estimated $396M.
- Arrowstreet Capital fully exited GE Aerospace in Q1 2014, selling an estimated $151M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $16.5B portfolio in Q1 2014.
- Arrowstreet Capital opened 416 new positions and closed 426 in Q1 2014.
- Arrowstreet Capital's portfolio value fell 10% quarter-over-quarter to $16.5B.
Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.